Number of the records: 1
Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2
- LIU, Yang. Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2022, 2022, vol. 69, no. 3, s. 571-582.
Number of the records: 1